These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25373386)

  • 1. Involvement of trace elements in the pathogenesis of prion diseases.
    Mizuno D; Koyama H; Ohkawara S; Sadakane Y; Kawahara M
    Curr Pharm Biotechnol; 2014; 15(11):1049-57. PubMed ID: 25373386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.
    Kawahara M; Koyama H; Nagata T; Sadakane Y
    Metallomics; 2011 Jul; 3(7):726-34. PubMed ID: 21442127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational conversion of prion protein in prion diseases.
    Zhou Z; Xiao G
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prion Concept and Synthetic Prions.
    Legname G; Moda F
    Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion protein and metal interaction: physiological and pathological implications.
    Singh N; Das D; Singh A; Mohan ML
    Curr Issues Mol Biol; 2010; 12(2):99-107. PubMed ID: 19767653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region.
    Perera WS; Hooper NM
    Curr Biol; 2001 Apr; 11(7):519-23. PubMed ID: 11413003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental approaches to TSE prevention via inhibition of prion formation.
    Politopoulou G
    Protein Pept Lett; 2004 Jun; 11(3):249-55. PubMed ID: 15182226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells.
    Hamanaka T; Nishizawa K; Sakasegawa Y; Oguma A; Teruya K; Kurahashi H; Hara H; Sakaguchi S; Doh-Ura K
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurometals in the Pathogenesis of Prion Diseases.
    Kawahara M; Kato-Negishi M; Tanaka KI
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of prion-induced modifications in membrane transport properties: implications for signal transduction and neurotoxicity.
    Kourie JI
    Chem Biol Interact; 2001 Oct; 138(1):1-26. PubMed ID: 11640912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenic mechanisms of prion diseases.
    Hur K; Kim JI; Choi SI; Choi EK; Carp RI; Kim YS
    Mech Ageing Dev; 2002 Nov; 123(12):1637-47. PubMed ID: 12470901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases.
    Choi CJ; Kanthasamy A; Anantharam V; Kanthasamy AG
    Neurotoxicology; 2006 Sep; 27(5):777-87. PubMed ID: 16860868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion disease: A loss of antioxidant function?
    Wong BS; Pan T; Liu T; Li R; Petersen RB; Jones IM; Gambetti P; Brown DR; Sy MS
    Biochem Biophys Res Commun; 2000 Aug; 275(2):249-52. PubMed ID: 10964653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of prion peptide structure and aggregation in toxicity and membrane binding.
    Rymer DL; Good TA
    J Neurochem; 2000 Dec; 75(6):2536-45. PubMed ID: 11080207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular prion protein neuroprotective function: implications in prion diseases.
    Roucou X; LeBlanc AC
    J Mol Med (Berl); 2005 Jan; 83(1):3-11. PubMed ID: 15645198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilizing NMR and EPR spectroscopy to probe the role of copper in prion diseases.
    Emwas AH; Al-Talla ZA; Guo X; Al-Ghamdi S; Al-Masri HT
    Magn Reson Chem; 2013 May; 51(5):255-68. PubMed ID: 23436479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion protein modulates cellular iron uptake: a novel function with implications for prion disease pathogenesis.
    Singh A; Mohan ML; Isaac AO; Luo X; Petrak J; Vyoral D; Singh N
    PLoS One; 2009; 4(2):e4468. PubMed ID: 19212444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions.
    Béland M; Roucou X
    J Neurochem; 2012 Mar; 120(6):853-68. PubMed ID: 22145935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.